Visiongain has published a new report entitled Military Simulation Modelling and Virtual Training 2023-2033. It includes profiles of Military Simulation.
Paris: The vaccine made by Pfizer and BioNTech appears to retain its effectiveness against coronavirus mutations in worrying new variants that have emerged recently in Britain and South Africa, the firms said Thursday.
Several new variants - each with a cluster of genetic mutations - have sparked fears over an increase in infectiousness as well as suggestions that the virus could begin to elude immune response, whether from prior infection or a vaccine.
Pfizer/BioNTech, which had previously said it was unlikely that the strain originally found in Britain could escape vaccine protection, said Thursday that early tests suggest their immunisation would be similarly protective against the variant in South Africa.
COVID-19: How long will the immunity against coronavirus last? gulfnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from gulfnews.com Daily Mail and Mail on Sunday newspapers.